FXM Research Miramar / Francisco Flores, M.D.

Center Information

Francisco Moncada, R.N., B.S.N., C.C.R.C.
President
FXM Research Miramar / Francisco Flores, M.D.
14601 SW 29th Street, Suite 208
Miramar, FL 33027
USA
954-430-1097
305-675-3152 (fax)
info@fxmresearch.com
www.fxmresearch.com
View Map

Contact Center

Currently Enrolling Trials

[Show More]

Therapeutic Areas

Dermatology

Center Overview

FXM Research is a privately owned and operated Clinical Research Site that conducts phase II, III, and IV clinical research trials specializing in Dermatology and Aesthetics/Cosmetics. Throughout the years, our ability to deliver aggressive, time bound enrollment goals, while providing trustworthy data to Pharmaceutical companies and CROs, has earned FXM Research a great deal of notoriety and fame within the Dermatology research industry.

Today, FXM Research’s success is widely regarded throughout our four operating branches: FXM Research Corp., based in Miami, Florida and home of our headquarters, FXM Research Miramar, located in the city of Miramar, Florida and FXM Research International, including two branches in Belize City, Central America.

At the core of our business and operating systems, FXM Research mission is to support pharmaceutical companies and CROs with introducing new and approved FDA medications successfully into the marketplace. We perform this efficiently and effectively by providing the highest quality service in a timely fashion and at the lowest possible cost.

  • Our primary concerns are subject safety and adherence to the protocol.
  • Turnover time for Regulatory Documents, budgets, and contracts is usually 24 to 48 hours.
  • We offer experienced, trained, and bilingual personnel (English and Spanish), who interact with our subjects, sponsors, and CROs as a cohesive team.
  • Our Principal Investigators are Board Certified Dermatologists and Certified Clinical Research Investigators with many years of extensive experience. They are located on-site and are available full-time.
  • Our Principal Investigators evaluate each and every study subject.
  • Most subjects are recruited through advertising and from the office of our PI's private practice, and/or FXM Research's extensive clinical database. We draw heavily from a Spanish speaking population, a group often under-represented in clinical trials.
  • We also have continuing extensive experience with a pediatric population.
  • We do whatever is necessary to accommodate our subjects' school and/or work schedule, which maximizes compliance and retention.

Clinical Research Experience

Since the year 2000, FXM Research group of companies have been involved with more than 55 of the most respected pharmaceutical companies and organizations in the world known as sponsors; conducting over 349 Clinical Trials in Dermatology.

We have acted as a clinical research site in numerous dermatological studies where our normal enrollment consists of well over 40 subjects with almost 99% compliance from such subjects.

The following are the main therapeutic conditions in dermatology that FXM Research group has conducted studies of:

  • Acne
  • Tinea Pedis
  • Rosacea
  • Psoriasis
  • Actinic Keratosis
  • Atopic Dermatitis
  • Onychomycosis
  • Tinea Cruris
  • Facial Wrinkles
  • Scalp Psoriasis
  • Tinea Pedis, Tinea Cruris, Tinea Corporis
  • Pediatric AD
  • Ichthyosis Vulgaris
  • Melasma
  • Molluscum
  • Tinea Versicolor
  • Hyperhidrosis of the Axillae
  • Infected Wounds
  • Hand Dermatitis
  • Tinea Capitis,
  • Tinea Corporis
  • Solar Lentigines

Below are the pharmaceutical companies whom have worked with FXM Research Miramar (Dr. Francisco Flores)

Company
Actavis
Allergan
Amgen
Anacor
Asubio
Bayer
Cutanea
Dow Pharmaceutical
DPT Laboratories
Eli Lilly
Foamix
Fougera
G&W Laboratories
Galderma
GenZum
Glenmark
Intendis
Maruho
Maruho North America
Medicis
Meiji
Merz
Nycomed US/Altana
Quinnova
Renaissance Pharma
SEEGPHARM
Stiefel
Taisho
Taro
TOLMAR Inc.
Viamet Pharmaceuticals
Warner Chilcott
Watson Laboratories
Grand Total

No. Studies
7
4
1
1
1
1
2
1
1
4
1
2
2
7
1
7
1
1
1
3
1
2
1
1
1
2
1
1
28
8
1
1
2
99

Investigator Experience


Francisco Flores, M.D.
Principal Investigator / FXM Research Miramar

FXM Research Miramar, with operations in the city of Miramar, FL; was founded in late 2008.
Today, the youngest of the four sites is proud to have conducted over 99 studies in Dermatology and Aesthetics/Cosmetics.

Our principal investigator, Francisco Flores, M.D., is on site full time. This is because our office houses both; our research site and Dr. Flores’ private practice.

Our site includes a designated research area with private examining rooms to provide confidentiality and comfort for our subjects. Furthermore, our facility also includes a secured area for studied medications, case report forms and record storage. A private office is also available to ensure comfortable, peaceful and undistracted monitoring visits for our CRA’s.

Our clinical research center is located inside the Miramar Medical Center,which is located on 14601 SW 29th Street, Suite 208, Miramar FL 33027.You could access Miramar Parkway (east) exiting I-75 expressway (North or South) on the 7th exit. You could access I-75 expressway from either The Florida Turnpike North or from Palmetto Expressway 826 (North or West).

Our FXM Miramar Facility is located 20 miles from Fort Lauderdale International Airport and 18 miles from Miami International Airport.


Dr. Francisco Flores, M.D., is a Board Certified Dermatologist with over 17 years of extensive
experience in the field of Dermatology.

As of late, Dr. Flores has conducted over 99 Clinical Research trials as the Principal Investigator for FXM Research Miramar in Miramar; FL.

Dr. Flores is an active member of the Association of Clinical Research Professionals (ACRP), the American Society of Dermatologic Surgery and the American Academy of Dermatology. He is also a Diplomat of the American Board of Dermatology.

Staff Expertise

Francisco Flores, M.D.
Principal Investigator

Dr. Flores is a board certified Dermatologist with over 17 years of extensive experience.
Furthermore, Dr. Flores has acted as Principal Investigator on over 99 successful Clinical Research trials.

Francisco Moncada, R.N., B.S.N., C.C.R.C.
President

Mr. Moncada is the President of the four separate branches
that structure FXM Research. Francisco Moncada has worked with Dr. Wiltz for over 24 years and has extensive experience in most dermatological conditions and disorders. In the year 2000, Mr. Moncada founded his first clinical research site FXM Research Corp. with operations in Miami, FL. Today, the site in Miami has conducted over 180 Clinical trials in dermatology under the Direction/Management of Mr. Moncada.

In late 2006, after many years of achieving outstanding results conducting clinical trials, Mr. Moncada widened his prospective to the international arena by founding FXM Research International which today, consists of two solid and experienced research sites in dermatology located in Belize City, Central America. Together, these sites have successfully conducted over 70 studies.

To further widen the scope of opportunities FXM Research has to offer to Pharmaceuticals and CRO Sponsors in the United States, the latest branch of FXM Research, FXM Research Miramar, with operations in the city of Miramar, FL; was founded in late 2008. Today, the youngest of the four sites is proud to have conducted over 99 studies in Dermatology. As Director, Mr. Moncada’ job is to handle all Regulatory aspects involved in the trials, oversee the success and achievement of all personnel assisting in the trials, and supervise subject’s conduct during the trial. Mr. Moncada’ management directive is to ensure all of the FXM Research sites convey the same unequivocal quality of standards each has to offer. Mr. Moncada has attended a GCP seminar, sponsored by ACRP, and completed Investigator Training for Medical research, sponsored by WIRB, along with Dr. Wiltz in May 2004. He is certified in HIV/OSHA/BBP-TB, CPR, ACLS, PALS, AND IATA regulations.

Maritza Blandon, Chief Finance Officer

Antonio Jimenez, BS. Chief Operating Officer

Maritza D. Diego, MMS, PA-C. Director of Clinical Research

Kevin Diego, BS. MBA. Director of Clinical Research

Michael A. Moreno, BS. MBA. Director of Finance

Jennifer D. Gutierrez, PA-C. Sub Investigator

Ana B. Retana, Clinical Research Coordinator

Rosalina F. Ortiz, BS. Clinical Research Coordinator

Chaveli M. Arocha, Clinical Research Coordinator

Orlando Adan, Lead Clinical Research Coordinator

Yaneysi Alonso, CMA Clinical Research Coordinator

Maria Ambros, RMA, Clinical Research Coordinator

Roberto A. Palmaz, Clinical Research Coordinator

Sandra E. Canizarez, Clinical Research Coordinator

Yasmelly Poggio, Executive Secretary

Silvana M. Martinez, Executive Secretary

Juliana Duran-Delgado, BS. Executive Secretary

Patient Demographics

We are always ranked among the highest enrolling sites in trials we participate in. This is
because of our extensive patient/subject database. Our patient/subject database consists of all patients treated in our PI's private practice, as well as, FXM’s own subject database.

Our patient/subject target population consists of the following and includes males and females of all age groups:

17% Hispanic
58% Caucasian
20% African American

2% Asian
3% Other

Our subjects give us several reasons why they decide to participate in our Clinical Research
studies. The ones they most often mention are:

  • To help in the development of new medications that may offer better treatment or even cures for chronic diseases.
  • The availability of diagnostic tests and medical evaluation of a particular disease or medical condition without worrying about the cost.
  • The Hope for a new approach or treatment that finally offers some relief. For all subjects' database management, we comply with privacy and confidentiality of all HIPAA regulations.

Other Information

For all regulatory issues we adhere to the assigned Central Institutional Review Board.

Contact Center

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the email form below. A representative from the research center will then follow up with you.